The breast cancer diagnostic market is expected to grow from USD 4.99 billion in 2019 to USD 9.04 billion by 2027, at a CAGR of 7.7% during the forecast period 2020-2027.
A cancer that develops when the tissues and cells in the breast begin to grow out of control is known as breast cancer. It is mainly observed in female. Symptoms of breast cancer are patches on the skin, lump in the breast, fluid leakage from the nipple, skin dimpling, and change in the shape of the breast. Certain screening tests can diagnose it at an early stage. Procedures used to stage breast cancer includes mammogram of the other breast to look for signs of cancer, bone scan, blood tests, breast MRI, positron emission tomography scan, and computerized tomography scan.
The factors driving the market are the rising number of breast cancer cases, increasing the need for initial and efficient detection, technological advancement, and growing insurance coverage and reimbursement for breast cancer diagnostics. Factors restraining the market growth are high cost of breast cancer diagnostics, untoward side effects of the imaging, and risks like excessive administration of barium and fluorescent contrast agents.
This study delivers a comprehensive analysis of type, end-user, and region. The type segment includes biopsy, blood tests, imaging, genomic tests, and others. Imaging holds the largest market share, owing to the rising preference of screening mammography, ultrasonography, diagnostics mammography, and breast MRI. Blood test segment is anticipated to witness significant growth, due to the large number of research studies conducted by research institutes. Blood test is useful for the detection of metastatic and recurring cancers at an early stage. Based on end-user, the market is segmented into diagnostic clinical laboratories, hospitals associated laboratories, ambulatory surgical centres, and cancer research centres. Hospital Associated Laboratories holds the largest share in the market, followed by diagnostics clinical laboratories.
The market has been divided into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. North America holds the largest market share and is anticipated to grow further, owing to rapid technological advancement, growing patient awareness, and well-established diagnostics infrastructure. In the region, Sweden and Japan have the highest survival rate. Europe holds the second-largest share in the market, owing to increasing awareness among people regarding regular check-up for early detection of breast cancer, and funding provided by the government in R&D of breast cancer diagnosis techniques. The Asia-Pacific region is expected to witness significant growth, owing to the increasing number of patients, government investments in healthcare expenditure, and rising awareness among people regarding the benefits of early detection of breast cancer.
Some of the notable players in the market are Becton, NanoString Technologies, Inc., Myriad Genetics Inc., Devicor Medical Products Inc., C.R. Bard, Inc., Paragon Biosciences, Genomic Health, Dickinson and Company, Koninklijke Philips N.V., Hologic Inc., and Danaher. In July 2019, Qlarity Imaging LLC was launched by Paragon Biosciences, it's seventh portfolio company to harness the value of artificial intelligence to improve medical outcomes.
Breast Cancer Diagnostic Market Analysis and Forecast, by Type
Breast Cancer Diagnostic Market Analysis and Forecast, by End-User
Breast Cancer Diagnostic Market Analysis and Forecast, by Region
Report Description:
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Type
4.3.2. Market Attractiveness Analysis By Application
4.3.3. Market Attractiveness Analysis By Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges
6. Global Breast Cancer Diagnostic Market Analysis and Forecast, By Type
6.1. Segment Overview
6.2. Biopsy
6.3. Blood Tests
6.4. Imaging
6.5. Genomic Tests
6.6. Others
7. Global Breast Cancer Diagnostic Market Analysis and Forecast, By Application
7.1. Segment Overview
7.2. Diagnostic Clinical Laboratories
7.3. Hospitals Associated Laboratories
7.4. Ambulatory Surgical centres
7.5. Cancer Research Centres
8. Global Breast Cancer Diagnostic Market Analysis and Forecast, By Regional Analysis
8.1. Segment Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.5. South America
8.5.1. Brazil
8.6. Middle East and Africa
8.6.1. UAE
8.6.2. South Africa
9. Global Breast Cancer Diagnostic Market-Competitive Landscape
9.1. Overview
9.2. Market Share of Key Players in Global Breast Cancer Diagnostic Market
9.2.1. Global Company Market Share
9.2.2. North America Company Market Share
9.2.3. Europe Company Market Share
9.2.4. APAC Company Market Share
9.3. Competitive Situations and Trends
9.3.1. Product Launches and Developments
9.3.2. Partnerships, Collaborations, and Agreements
9.3.3. Mergers & Acquisitions
9.3.4. Expansions
10. Company Profiles
10.1. Becton Dickinson and Company
10.1.1. Business Overview
10.1.2. Company Snapshot
10.1.3. Company Market Share Analysis
10.1.4. Company Product Portfolio
10.1.5. Recent Developments
10.1.6. SWOT Analysis
10.2. NanoString Technologies, Inc.
10.2.1. Business Overview
10.2.2. Company Snapshot
10.2.3. Company Market Share Analysis
10.2.4. Company Product Portfolio
10.2.5. Recent Developments
10.2.6. SWOT Analysis
10.3. Myriad Genetics Inc.
10.3.1. Business Overview
10.3.2. Company Snapshot
10.3.3. Company Market Share Analysis
10.3.4. Company Product Portfolio
10.3.5. Recent Developments
10.3.6. SWOT Analysis
10.4. Devicor Medical Products Inc.
10.4.1. Business Overview
10.4.2. Company Snapshot
10.4.3. Company Market Share Analysis
10.4.4. Company Product Portfolio
10.4.5. Recent Developments
10.4.6. SWOT Analysis
10.5. C.R. Bard, Inc.
10.5.1. Business Overview
10.5.2. Company Snapshot
10.5.3. Company Market Share Analysis
10.5.4. Company Product Portfolio
10.5.5. Recent Developments
10.5.6. SWOT Analysis
10.6. Paragon Biosciences
10.6.1. Business Overview
10.6.2. Company Snapshot
10.6.3. Company Market Share Analysis
10.6.4. Company Product Portfolio
10.6.5. Recent Developments
10.6.6. SWOT Analysis
10.7. Genomic Health
10.7.1. Business Overview
10.7.2. Company Snapshot
10.7.3. Company Market Share Analysis
10.7.4. Company Product Portfolio
10.7.5. Recent Developments
10.7.6. SWOT Analysis
10.8. Koninklijke Philips N.V.
10.8.1. Business Overview
10.8.2. Company Snapshot
10.8.3. Company Market Share Analysis
10.8.4. Company Product Portfolio
10.8.5. Recent Developments
10.8.6. SWOT Analysis
10.9. Hologic Inc.
10.9.1. Business Overview
10.9.2. Company Snapshot
10.9.3. Company Market Share Analysis
10.9.4. Company Product Portfolio
10.9.5. Recent Developments
10.9.6. SWOT Analysis
10.10. Danaher
10.10.1. Business Overview
10.10.2. Company Snapshot
10.10.3. Company Market Share Analysis
10.10.4. Company Product Portfolio
10.10.5. Recent Developments
10.10.6. SWOT Analysis
List of Table
1. Global Breast Cancer Diagnostic Market, By Type, 2017–2027(USD Billion)
2. Global Biopsy In Breast Cancer Diagnostic Market, By Region, 2017–2027(USD Billion)
3. Global Blood Tests In Breast Cancer Diagnostic Market, By Region, 2017–2027(USD Billion)
4. Global Imaging In Breast Cancer Diagnostic Market, By Region, 2017–2027(USD Billion)
5. Global Genomic Tests In Breast Cancer Diagnostic Market, By Region, 2017–2027(USD Billion)
6. Global Others In Breast Cancer Diagnostic Market, By Region, 2017–2027(USD Billion)
7. Global Breast Cancer Diagnostic Market, By Application, 2017–2027(USD Billion)
8. Global Diagnostic Clinical Laboratories Breast Cancer Diagnostic Market, By Region, 2017–2027(USD Billion)
9. Global Hospitals Associated Laboratories Breast Cancer Diagnostic Market, By Region, 2017–2027 (USD Billion)
10. Global Ambulatory Surgical centres Breast Cancer Diagnostic Market, By Region, 2017–2027 (USD Billion)
11. Global Cancer Research Centres Breast Cancer Diagnostic Market, By Region, 2017–2027 (USD Billion)
12. Global Breast Cancer Diagnostic Market, By Region, 2017–2027(USD Billion)
13. Global Breast Cancer Diagnostic Market, By North America, 2017–2027(USD Billion)
14. North America Breast Cancer Diagnostic Market, By Type, 2017–2027(USD Billion)
15. North America Breast Cancer Diagnostic Market, By Application, 2017–2027(USD Billion)
16. U.S. Breast Cancer Diagnostic Market, By Type, 2017–2027(USD Billion)
17. U.S. Breast Cancer Diagnostic Market, By Application, 2017–2027(USD Billion)
18. Canada Breast Cancer Diagnostic Market, By Type, 2017–2027(USD Billion)
19. Canada Breast Cancer Diagnostic Market, By Application, 2017–2027(USD Billion)
20. Mexico Breast Cancer Diagnostic Market, By Type, 2017–2027(USD Billion)
21. Mexico Breast Cancer Diagnostic Market, By Application, 2017–2027(USD Billion)
22. Europe Breast Cancer Diagnostic Market, By Type, 2017–2027(USD Billion)
23. Europe Breast Cancer Diagnostic Market, By Application, 2017–2027(USD Billion)
24. Germany Breast Cancer Diagnostic Market, By Type, 2017–2027(USD Billion)
25. Germany Breast Cancer Diagnostic Market, By Application, 2017–2027(USD Billion)
26. France Breast Cancer Diagnostic Market, By Type, 2017–2027(USD Billion)
27. France Breast Cancer Diagnostic Market, By Application, 2017–2027(USD Billion)
28. U.K. Breast Cancer Diagnostic Market, By Type, 2017–2027(USD Billion)
29. U.K. Breast Cancer Diagnostic Market, By Application, 2017–2027(USD Billion)
30. Italy Breast Cancer Diagnostic Market, By Type, 2017–2027(USD Billion)
31. Italy Breast Cancer Diagnostic Market, By Application, 2017–2027(USD Billion)
32. Spain Breast Cancer Diagnostic Market, By Type, 2017–2027(USD Billion)
33. Spain Breast Cancer Diagnostic Market, By Application, 2017–2027(USD Billion)
34. Asia Pacific Breast Cancer Diagnostic Market, By Type, 2017–2027(USD Billion)
35. Asia Pacific Breast Cancer Diagnostic Market, By Application, 2017–2027(USD Billion)
36. Japan Breast Cancer Diagnostic Market, By Type, 2017–2027(USD Billion)
37. Japan Breast Cancer Diagnostic Market, By Application, 2017–2027(USD Billion)
38. China Breast Cancer Diagnostic Market, By Type, 2017–2027(USD Billion)
39. China Breast Cancer Diagnostic Market, By Application, 2017–2027(USD Billion)
40. India Breast Cancer Diagnostic Market, By Type, 2017–2027(USD Billion)
41. India Breast Cancer Diagnostic Market, By Application, 2017–2027(USD Billion)
42. South America Breast Cancer Diagnostic Market, By Type, 2017–2027(USD Billion)
43. South America Breast Cancer Diagnostic Market, By Application, 2017–2027(USD Billion)
44. Brazil Breast Cancer Diagnostic Market, By Type, 2017–2027(USD Billion)
45. Brazil Breast Cancer Diagnostic Market, By Application, 2017–2027(USD Billion)
46. Middle East and Africa Breast Cancer Diagnostic Market, By Type, 2017–2027(USD Billion)
47. Middle East Breast Cancer Diagnostic Market, By Application, 2017–2027(USD Billion)
48. UAE Breast Cancer Diagnostic Market, By Type, 2017–2027(USD Billion)
49. UAE Breast Cancer Diagnostic Market, By Application, 2017–2027(USD Billion)
50. South Africa Breast Cancer Diagnostic Market, By Type, 2017–2027(USD Billion)
51. South Africa Breast Cancer Diagnostic Market, By Application, 2017–2027(USD Billion)
List of Figures
1. Global Breast Cancer Diagnostic Market Segmentation
2. Breast Cancer Diagnostic Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Breast Cancer Diagnostic Market Attractiveness Analysis By Type
9. Global Breast Cancer Diagnostic Market Attractiveness Analysis By Application
10. Global Breast Cancer Diagnostic Market Attractiveness Analysis By Region
11. Global Breast Cancer Diagnostic Market: Dynamics
12. Global Breast Cancer Diagnostic Market Share By Type (2019 & 2027)
13. Global Breast Cancer Diagnostic Market Share By Application (2019 & 2027)
14. Global Breast Cancer Diagnostic Market Share by Regions (2019 & 2027)
15. Global Breast Cancer Diagnostic Market Share by Company (2019)
Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.
Market research is valuable because of the following reasons:
Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.
Our market research process involves with the four specific stages.
Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:
Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:
Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.
This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.
Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.
Free Customization
Countries can be added on demand
Free yearly update on purchase of Multi/Corporate User License
Companies served till date
We serve our customers 24x7 for 365 days through calls, emails and live chat options.
Huge database of exceptional market reports bringing market intelligence to your fingertips.
SSL enabled, we offer you various secured payment options for risk free purchase.